Affinity maturation of phage display antibody populations using ribosome display

Journal of Immunological Methods

Volumn 313, Issue 1-2, 2006, Pages 129-139

  Groves, Maria ^a   Lane, Steven ^a   Douthwaite, Julie ^a   Lowne, David ^a   Gareth Rees, D ^a   Edwards, Bryan ^a   Jackson, Ronald H ^a  

^a MEDIMMUNE LTD   (United Kingdom)

Author keywords

Antibody; Insulin; Phage display; Ribosome display

Indexed keywords

ANTIBODY; ANTIGEN; BIOLOGICAL MARKER; BOVINE INSULIN; GLYCINE; IMMUNOGLOBULIN G; INSULIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; SODIUM CHLORIDE; VALINE;

ANTIBODY AFFINITY; ANTIBODY ISOLATION; ARTICLE; BINDING AFFINITY; CLONING; CONCENTRATION (PARAMETERS); HUMAN; INTERMETHOD COMPARISON; MUTAGENESIS; MUTATION; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; RIBOSOME;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES; ANTIBODY AFFINITY; CATTLE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN VARIABLE REGION; INSULIN; KINETICS; MOLECULAR SEQUENCE DATA; MUTAGENESIS; PEPTIDE LIBRARY; POLYMERASE CHAIN REACTION; RIBOSOMES;

BOS TAURUS;

EID: 33745713529     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.04.002     Document Type: Article

References (36)

1. Baker M. In biomarkers we trust?. Nat. Biotechnol. 23 (2005) 297
2. Baker K.P., Edwards B.M., Main S.H., Choi G.H., Wager R.E., Halpern W.G., Lappin P.B., Riccobene T., Abramian D., Sekut L., Sturm B., Poortman C., Minter R.R., Dobson C.L., Williams E., Carmen S., Smith R., Roschke V., Hilbert D.M., Vaughan T.J., and Albert V.R. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator. Arthritis Rheum. 48 (2003) 3253
3. Her2 antibody for human cancer therapy. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 4285
4. Chen H.Z., and Zubay G. Prokaryotic coupled transcription-translation. Methods Enzymol. 101 (1983) 674
5. Chen Y., Wiesmann C., Fuh G., Li B., Christinger H.W., McKay P., de Vos A.M., and Lowman H.B. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. J. Mol. Biol. 293 (1999) 865
6. Edwards B.M., Barash S.C., Main S.H., Choi G.H., Minter R., Ullrich S., Williams E., Du Fou L., Wilton J., Albert V.R., and Vaughan T.J. The remarkable flexibility of the human antibody repertoire; isolation of over one thousand different antibodies to a single protein, BLyS. J. Mol. Biol. 334 (2003) 103
7. Frank R., and Hargreaves R. Clinical biomarkers in drug discovery and development. Nat. Rev. Drug Discov. 2 (2003) 566
8. Groves M.A.T., and Osbourn J.K. Applications of ribosome display to antibody drug discovery. Exper. Opin. Biol. Ther. 5 (2005) 125
9. Hanes J., and Pluckthun A. In vitro selection and evolution of functional proteins by using ribosome display. Proc. Natl. Acad. Sci.U. S. A. 94 (1997) 4937
10. Hanes J., Jermutus L., Weber-Bornhauser S., Bosshard H.R., and Pluckthun A. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 14130
11. Hanes J., Schaffitzel C., Knappik A., and Pluckthun A. Picomolar antibodies from a fully synthetic naïve library selected and evolved by ribosome display. Nat. Biotechnol. 18 (2000) 1287
12. Hanes J., Jermutus L., and Pluckthun A. Selecting and evolving functional proteins by ribosome display. Methods Enzymol. 328 (2000) 404
13. Hawkins R.E., Russell S.J., and Winter G. Selection of phage antibodies by binding affinity. Mimicking affinity maturation. J. Mol. Biol. 226 (1992) 889
14. He M., Menges M., Groves M.A., Corps E., Liu H., Bruggemann M., and Taussig M.J. Selection of a human anti-progesterone antibody fragment from a transgenic mouse library by ARM ribosome display. J. Immunol. Methods 231 (1999) 105
15. Hoet R.M., Cohen E.H., Kent R.B., Rookey K., Schoonbroodt S., Hogan S., Rem L., Frans N., Daukandt M., Pieters H., van Hegelsom R., Coolen-van Neer N., Nastri H.G., Rondon I.J., Leeds J.A., Hufton S.E., Huang L., Kashin I., Devlin M., Kuang G., Steukers M., Viswanathan M., Nixon A.E., Sexton D.J., Hoogenboom H.R., and Ladner R.C. Generation of high-affinity human antibodies by combining donor-derived and synthetic complementary-determining-region diversity. Nat. Biotechnol. 23 (2005) 344
16. Hudson P.J., and Souriau C. Engineered antibodies. Nat. Med. 9 (2003) 129
17. Hutchings C., Carmen S., and Lennard S. Generation of Naïve Human Antibody Libraries. In: Kontermann R., and Dubel S. (Eds). 'Antibody Engineering' Springer Laboratory Manuals, Berlin (2001) 93
18. Liu Z., Panousis C., Smyth F.E., Murphy R., Wirth V., Cartwright G., Johns T.G., and Scott A.M. Generation of anti-idiotype antibodies for application in clinical immunotherapy laboratory analyses. Hybridoma and Hybridomics vol. 22 (2003) 219
19. Jermutus L., Honegger A., Schwesinger F., Hanes J., and Pluckthun A. Tailoring in vitro evolution for protein affinity or stability. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 75
20. McCafferty J., Griffiths A.D., Winter G., and Chiswell D. Phage antibodies: filamentous phage displaying antibody variable domains. Nature 348 (1990) 552
21. McCafferty J., FitzGerald K.J., Earnshaw J., Chiswell D.J., Link J., Smith R., and Kenten J. Selection and rapid purification of murine antibody fragments that bind a transitionstate analog by phage display. Appl. Biochem. Biotechnol. 47 (1994) 157
22. Muller Y.A., Chen Y., Christinger H.W., Li B., Cunningham B.C., Lowman H.B., and de Vos A.M. VEGF and Fab fragment of a humanized neutralizing antibody: crystal structure of the complex at 2.4 Å resolution and mutational analysis of the interface. Structure 6 (1998) 1153
23. Nissim A., Hoogenboom H.R., Tomlinson I.M., Flynn G., Midgley C., Lane D., and Winter G. Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J. 3 (1994) 692
24. Osbourn J.K., Field A., Wilton J., Derbyshire E., Earnshaw J.C., Jones P.T., Allen D., and McCafferty J. Generation of a panel of related human scFv antibodies with high affinities for human CEA. Immunotechnology 2 (1996) 181
25. Osbourn J., Groves M., and Vaughan T. From rodent reagents to human therapeutics using antibody guided selection. Methods 36 (2005) 61
26. Persic L., Roberts A., Wilton J., Cattaneo A., Bradbury A., and Hoogenboom H.R. An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene 187 (1997) 9
27. Pukac L., Kanakaraj P., Humphreys R., Alderson R., Bloom M., Sung C., Riccobene T., Johnson R., Fiscella M., Mahoney A., Carrell J., Boyd E., Yao X.T., Zhang L., Zhong L., von Kerczek A., Shepard L., Vaughan T., Edwards B., Dobson C., Salcedo T., and Albert V. HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo. Br. J. Cancer 92 (2005) 1430
28. Schier R., McCall A., Adams G.P., Marshall K.W., Merritt H., Yim M., Crawford R.S., Weiner L.M., Marks C., and Marks J.D. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antigen binding site. J. Mol. Biol. 263 (1996) 551
29. Shimizu Y., Inoue A., Tomari Y., Suzuki T., Yokogawa T., Nishikawa K., and Ueda T. Cell-free translation reconstituted with purified components. Nat. Biotechnol. 19 (2001) 751
30. Shirai H., Kidera A., and Nakamura H. H3-rules: identification of CDR-H3 structures in antibodies. FEBS Lett. 455 (1999) 188
31. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228 (1985) 1315
32. Thompson J.E., Vaughan T.J., Williams A.J., Wilton J., Johnson K.S., Bacon L., Green J.A., Ruddock S., Martins M., Pope A.R., Tempest P.R., and Jackson R.H. A fully human antibody neutralising biologically active TGFβ2 for use in therapy. J. Immunol. Methods 227 (1999) 17
33. Tomlinson I.M., Walter G., Marks J.D., Llewelyn M.B., and Winter G. The repertoire of human germline VH sequences reveals about fifty groups of VH segments with different hypervariable loops. J. Mol. Biol. 227 (1992) 776
34. Yang W.-P., Green K., Pinz-Sweeney S., Briones A.T., Burton D.R., and Barbas C.F. CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV1 antibody into the picomolar range. J. Mol. Biol. 254 (1995) 392
35. Yau K.Y.F., Groves M.A.T., Li S., Sheedy C., Lee H., Tanha J., MacKenzie C.R., Jermutus L., and Hall J.C. Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library. J. Immunol. Methods 281 (2003) 161
36. Zahnd C., Spinelli S., Luginbuhl B., Amstutz P., Cambillau C., and Pluckthun A. Directed in vitro evolution and crystallographic analysis of a single chain antibody fragment (scFv) with low picomolar affinity. J. Biol. Chem. 279 (2004) 18870